HYBRID EVENT: You can participate in person at London or Virtually from your home or work.
Neonatal Seizures

Neonatal seizures represent a distinctive and intricate spectrum of neurological disturbances that manifest in the first 28 days of life, posing significant challenges for clinicians, caregivers, and affected infants alike. Characterized by abnormal, synchronized electrical activity in the developing brain, neonatal seizures encompass a diverse array of etiologies, ranging from acute birth-related complications to underlying neurological disorders. Their occurrence can be subtle, marked by subtle facial movements or eye fluttering, or overt, featuring tonic, clonic, or myoclonic convulsions, making timely and accurate diagnosis a formidable task. Etiological factors include hypoxic-ischemic events, metabolic abnormalities, infections, structural malformations, and genetic predispositions, necessitating a meticulous and comprehensive evaluation to pinpoint the root cause. The neonatal brain's vulnerability further complicates the scenario, as seizures may adversely impact neurodevelopmental outcomes, emphasizing the critical need for prompt intervention. Diagnostic modalities such as electroencephalography (EEG) play a pivotal role in confirming the presence of seizures and guiding treatment decisions, while neuroimaging techniques assist in identifying structural anomalies. Pharmacological management, primarily with antiepileptic drugs, forms the cornerstone of treatment, although challenges arise due to the delicate balance required to control seizures without compromising the fragile neonatal brain. The intricate interplay of neonatal physiology, pharmacokinetics, and underlying pathology underscores the importance of a multidisciplinary approach involving neonatologists, neurologists, radiologists, and genetic specialists. Neonatal seizures, therefore, represent not only a clinical emergency but also a complex puzzle demanding meticulous unraveling to optimize outcomes and pave the way for improved understanding and management strategies in this vulnerable population.

Committee Members
Speaker at Pediatrics and Neonatology 2025 - Steven M Donn

Steven M Donn

University of Michigan Health, United States
Speaker at Pediatrics and Neonatology 2025 - Renee J Dufault

Renee J Dufault

Food Ingredient and Health Research Institute, United States
Speaker at Pediatrics and Neonatology 2025 - Catherine Fallet Bianco

Catherine Fallet Bianco

Sainte-Justine University Hospital, Canada
Speaker at Pediatrics and Neonatology 2025 - Heather Hanna

Heather Hanna

Imperial College, United Kingdom
EPN 2025 Speakers
Speaker at Pediatrics and Neonatology 2025 - Ann L Smith

Ann L Smith

Novant Health Forsyth Medical Center, United States
Speaker at Pediatrics and Neonatology 2025 - Michael Ginzburg

Michael Ginzburg

UC Davis Health, United States
Speaker at Pediatrics and Neonatology 2025 - Adonna Francis

Adonna Francis

Imperial College, United Kingdom
Speaker at Pediatrics and Neonatology 2025 - Jo Vrancken

Jo Vrancken

PXL University College, Belgium
Speaker at Pediatrics and Neonatology 2025 - Bilal Tahir

Bilal Tahir

James Paget University Hospital, United Kingdom
Speaker at Pediatrics and Neonatology 2025 - Reshma Vithayathil

Reshma Vithayathil

Bedford Hospital, United Kingdom

Submit your abstract Today

Watsapp